News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
Clinical - Approvals (World)
European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval Of IMBRUVICA® (Ibrutinib) For Treatment Of Two Blood Cancers 7/25/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: PLEGRIDY™ (Peginterferon beta-1a) Approved In The European Union For The Treatment Of Multiple Sclerosis 7/24/2014
Health Canada Approves Kane Biotech Inc. (KNE)'s DispersinB® For Human Use 7/23/2014
Starpharma: VivaGel® Condom Receives TGA Device Certification - Launch Preparations To Follow 7/21/2014
Hamilton Thorne, Inc. Receives Notification Of Grant Of Patent Right And CFDA Approval To Market Its LYKOS(R) Laser System In China 7/16/2014
MediWound (MDWD) Announces NexoBrid Marketing Approval From Israeli Ministry of Health 7/16/2014
Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval Of APTIOM(TM) (eslicarbazepine acetate) As A Once-Daily Adjunctive Treatment For Partial-Onset Seizures In Patients With Epilepsy 7/11/2014
Can-Fite BioPharma (CFBI)'s CF102 Approved For Compassionate Use In Israel For Liver Cancer Patient 7/10/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: Swissmedic Approves AMITIZA® (Lubiprostone) For The Treatment Of Opioid-Induced Constipation 7/8/2014
Bayer Inc. Release: Nexavar® (sorafenib tablets) Now Approved In Canada For The Treatment Of Differentiated Thyroid Cancer 7/7/2014
Japan Becomes First Country To Approve Roche (RHHBY)'s Alectinib For People With A Specific Form Of Advanced Lung Cancer 7/7/2014
BioMarin Pharmaceutical Inc. (BMRN) Announces Health Canada Approval Of VIMIZIM™ (elosulfase alfa) For The Treatment Of Morquio A Syndrome 7/7/2014
Bristol-Myers Squibb Company (BMY) Release: Japan Approves First All-Oral, Interferon- And Ribavirin-Free Hepatitis C Treatment, Daklinza® (Daclatasvir) And Sunvepra®(Asunaprevir) Dual Regimen 7/7/2014
Theravance, Inc. (THRX) Release: Anoro® Ellipta® (Umeclidinium/Vilanterol) Gains Approval In Japan For The Treatment Of COPD 7/7/2014
FDA Approves Novo Nordisk A/S (NVO)'s NovoSeven® RT To Treat Glanzmann's Thrombasthenia (GT) With Refractoriness 7/7/2014
Flamel Technologies (FLML) Wins FDA Approval For VAZCULEP 6/30/2014
pSivida Corp (PSDV)'s Iluvien Gets Marketing Authorizations In 10 More EU Countries 6/30/2014
India's Ranbaxy Laboratories (RANBAXY.BO) Wins FDA Approval For Novartis AG (NVS)'s Diovan Generic 6/27/2014
NeuroMetrix, Inc. (NURO) Reports Japan Regulatory Approval For NC-stat DPNCheck 6/24/2014
Hengrui Medicine Granted Approval To Market Cancer Drug In U.S. 6/24/2014
Roche (RHHBY) Medicine Gazyvaro Granted Approval For The Therapy Of Patients With Previously Untreated Chronic Lymphocytic Leukemia And Co-Existing Medical Conditions In Switzerland 6/18/2014
Sanofi Pasteur (SASY.PA) Release: Gardasil® Approved In Europe For The Prevention Of Anal Cancer 6/18/2014
Teva Pharmaceutical Industries Limited (TEVA): FDA Clears Expanded Label For AZILECT® For Treatment Across All Stages Of Parkinson's Disease 6/9/2014
Boehringer Ingelheim Corporation's Pradaxa® Wins EU Approval To Treat Deep Vein Thrombosis And Pulmonary Embolisms 6/6/2014
Janssen-Cilag International NV Release: INVEGA® Receives European Commission Approval To Extend Its Adult Indication For Treatment Of Schizophrenia To Include Adolescents Aged 15 Years And Older 6/4/2014
Bayer HealthCare (BAY) Receives EU Approval For Nexavar (Sorafenib) For The Treatment Of Differentiated Thyroid Cancer 5/30/2014
FDA Green Lights Eisai Inc. (ESALF.PK)'s ALOXI ®To Prevent Nausea And Vomiting Due To Chemotherapy In Kids 5/29/2014
Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Approval For QVAR® 5/27/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Entyvio Wins FDA Approval For Severe Colitis 5/22/2014
Novartis AG (NVS) Release: First Myelofibrosis Medication For Life-Threatening Blood Cancer Approved In Singapore 5/15/2014
Actavis (ACT) Receives Final Approval For Generic Version Of Exalgo® 5/14/2014
Perrigo Company (PRGO) Announces FDA Approval Of Generic Version Of Astepro® Nasal Spray 5/12/2014
FDA Approves Teva Pharmaceutical Industries Limited (TEVA)'s SYNRIBO® For Injection For Home Administration 5/5/2014
FDA Approves Ibalizumab Manufactured By WuXi PharmaTech Co., Ltd. For Treatment Of Patients On Expanded Access 5/5/2014
Apricus Biosciences (APRI) Announces National Phase Approval For Vitaros® In Spain 4/24/2014
GlaxoSmithKline (GSK), Genmab A/S (GEN.CO) Wins FDA Approval For Arzerra As First-Line Treatment For Chronic Lymphocytic Leukaemia (CLL) 4/18/2014
FDA Approves GlaxoSmithKline (GSK)'s Tanzeum To Treat Type 2 Diabetes 4/15/2014
Teva Pharmaceutical Industries Limited (TEVA) First Approval And Launch Of Generic Lovaza® Capsules In The United States 4/8/2014
Sanofi Pasteur (SASY.PA) Release: Gardasil® Approved In The European Union For A 2-Dose Schedule In Children Aged From 9 To 13 Years 4/7/2014
Stallergenes, S.A. (GENP.PA) Wins FDA's Go-Ahead For Oralair Allergy Pill 4/2/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Gets Approval For Influenza Vaccines 3/31/2014
Swedish Orphan Biovitrum: FDA Approves Alprolix™ 3/31/2014
GlaxoSmithKline (GSK)'s Type 2 Diabetes Drug Eperzan® Wins EU Approval 3/27/2014
Actavis (ACT) And Valeant Pharmaceuticals International (VRX) Announce FDA Approval For Metronidazole 1.3% 3/26/2014
Astellas Pharma Inc. (ALPMY) Announces Marketing Approval In Japan For XTANDI® (Enzalutamide) Capsules, An Advanced Prostate Cancer Treatment 3/25/2014
Otsuka Pharmaceutical Co., Ltd.'s Samsca® Approved In Japan As The World's First Drug Therapy For ADPKD, A Rare Kidney Disease 3/24/2014
Medivir AB (MVRBF): Simeprevir Has Now Been Approved In Russia 3/24/2014
Pierre Fabre Obtains FDA Approval To Market Hemangeo™ For The Treatment Of Infantile Hemangioma 3/18/2014
Starpharma Holdings Ltd Release: Vivagel®-Coated Condom Approved For Marketing In Japan 3/14/2014
TaiGen Biotechnology Granted Taiwanese Approval For Novel Antibiotic 3/13/2014
Northwest Biotherapeutics (NWBO) Jumps As Germany Permits Sale Of Brain Cancer Drug 3/11/2014
Boehringer Ingelheim Corporation Release: Pradaxa® (Dabigatran Etexilate) Now Approved In Over 100 Countries For Stroke Prevention In Atrial Fibrillation 3/6/2014
Vectura Group plc (VEC.L): South Korean Regulatory Authority Confirm Approval Of AirFluSal® Forspiro® 2/28/2014
Oasmia Wins FDA Conditional Approval For Paccal Vet In Two Canine Cancers 2/28/2014
BioDiem Ltd. (BDM.AX)'s Announcement Of Approval Of LAIV Seasonal Flu Vaccine In India 2/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Full FDA Approval Of SYNRIBO® (Omacetaxine Mepesuccinate) For Injection 2/13/2014
The Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S (LUN.CO) Alliance Announces Once-Monthly (Pr)ABILIFY MAINTENA(™) (ARIPIPRAZOLE For Prolonged Release Injectable Suspension)1 Now Approved In Canada For The Maintenance Treatment Of Schizophrenia In Stabilized Adult Patients 2/13/2014
Vectura Group plc (VEC.L) Release: Norwegian Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 2/10/2014
Genzyme Corporation (GENZ)’s Lemtrada® Approved In Mexico For Treatment Of Multiple Sclerosis 2/4/2014
Perrigo Company (PRGO) Receives FDA Final Approval For Generic Equivalent To Prandin® 1/24/2014
Miltenyi Biotec, Inc. Receives FDA Approval For Clinimacs® CD34 Reagent System For Prevention Of Graft-Versus-Host Disease In The Treatment Of Acute Myeloid Leukemia 1/24/2014
AstraZeneca PLC (AZN)'s Diabetes Drug Xigduo Approved In Europe 1/23/2014
Apricus Biosciences (APRI)Announces National Phase Approval For Erectile Dysfunction Cream - Vitaros® In Belgium 1/23/2014
Aegerion Pharmaceuticals, Inc. (AEGR)'s JUXTAPID® Capsules Approved In Mexico 1/20/2014
Keryx Biopharmaceuticals (KERX) Announces Marketing Approval Of Ferric Citrate In Japan 1/17/2014
Vectura Group plc (VEC.L) Hungarian Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/16/2014
Vectura Group plc (VEC.L) German Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/13/2014
GlaxoSmithKline (GSK) Gains Accelerated FDA Approval For Combination Use Of Mekinist® (Trametinib) And Tafinlar® (Dabrafenib) 1/9/2014
Celgene International Sárl (CELG) Release: ABRAXANE® Plus Gemcitabine Receives European Marketing Authorization For First-Line Treatment Of Patients With Metastatic Pancreatic Cancer 1/7/2014
Lundbeck Inc. (LUN.CO) Wins EU Marketing Approval For Brintellix To Treat Adult Depression 1/3/2014
Actelion Ltd. (ALIOF.PK)'s New Blood Pressure Drug Get EU Nod 12/23/2013
Biota Pharmaceuticals, Inc. Reports That Laninamivir Octanoate Is Approved For The Prevention Of Influenza In Japan 12/23/2013
Kanghong Pharma Gains CFDA Approval For China's First Innovative MAb 12/23/2013
GlaxoSmithKline (GSK), Theravance, Inc. (THRX)'s Second Lung Drug ANORO™ ELLIPTA™ Wins FDA Approval 12/20/2013
Vectura Group plc (VEC.L): Danish Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 12/18/2013
AstraZeneca PLC (AZN)'s Fluenz Tetra Gets European Marketing Grant 12/6/2013
European Medicines Agency Approves Once Every Two Weeks Dosing Option For CSL Behring UK Ltd's Hizentra® (Human Normal Immunoglobulin, SCIg) 12/5/2013
Fresenius Medical Care's Velphoro® (PA21) Receives FDA Approval 12/2/2013
GW Pharmaceuticals Announces Sativex® Regulatory Approval In Switzerland 11/27/2013
Mylan Inc. (MYL)-BioCon Limited (BIOCON.NS) Receive First Indian Biosimilar Regulatory Approval For Herceptin® 11/26/2013
BTG plc (BTG.L) Surges As Varicose Vein Treatment Grabs FDA Approval; Stock Up +13.75% At Market Close (November 26, 2013) 11/26/2013
Janssen-Cilag International NV (JNJ)'s INVOKANA™ Wins Approval In The EU For Type 2 Diabetes Patients 11/26/2013
GlaxoSmithKline (GSK)'s Pioneering Bird Flu Vaccine Gets FFA Sciences Approval 11/25/2013
Bavarian Nordic (BAVA.CO) Receives Health Canada Approval Of IMVAMUNE Smallpox Vaccine 11/22/2013
EU Approves Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S (LUN.CO)'s Once-Monthly Abilify Maintena® For Schizophrenia 11/21/2013
Swedish Orphan Biovitrum Receives Approval For Kineret® For Treatment Of Rare Disease CAPS 11/20/2013
EU Approval For Bayer AG (BAYN.DE)'s Prostate Cancer Drug 11/19/2013
GlaxoSmithKline (GSK)'s Asthma Drug Relvar Approved In Europe 11/18/2013
Bayer HealthCare (BAY) Receives Approval For Xofigo® (radium Ra 223 dichloride) Injection In Europe 11/15/2013
Hong Kong Authority Approves Mundipharma AG's Flutiform® (fluticasone propionate/formoterol fumarate), a New Treatment for Asthma 11/8/2013
Lupin Ltd. (LUPN.BO) Receives FDA Approval for its New Drug Application for Antara® Capsules 10/23/2013
Basilea Pharmaceutica (BSLN.SW): Antibiotic Ceftobiprole Obtains Regulatory Approval in Europe for Pneumonia 10/23/2013
Boehringer Ingelheim Corporation's New Once-Daily Striverdi* (Olodaterol) Respimat® Gains Approval in First EU Countries 10/18/2013
Novo Nordisk Canada Inc. (NVO) Release: Health Canada Approves Levemir® Flextouch® Prefilled Insulin Pen for the Treatment of Type 1 and Type 2 Diabetes 10/18/2013
UCB Group (UCBJF.PK)'s Cimzia® (Certolizumab Pegol) Approved by FDA for Treatment of Adults With Active Ankylosing Spondylitis 10/18/2013
Novo Nordisk A/S (NVO)'s Novoeight Wins FDA Approval for Hemophilia A 10/16/2013
Teva Pharmaceutical Industries Limited (TEVA) Announces FDA Approval of Generic TOBI® in the United States 10/14/2013
FDA Approves Sanofi (France) (SAN.PA)'s Nasacort® Allergy 24HR for Over-the-Counter Use 10/11/2013
Lundbeck Inc. (LUN.CO), Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Win FDA Approval for Depression Drug 10/1/2013
UCB, Inc. (UCBJF.PK)'s Cimzia® Wins FDA Approval for Psoriatic Arthritis 9/30/2013
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in South Africa 9/30/2013
CSL Behring Gains Approval to License Hizentra® in Japan for the Treatment of Primary Immunodeficiency and Secondary Immunodeficiency 9/27/2013
Medivir AB (MVIRb.F)'s Simeprevir Has Been Approved in Japan for the Treatment of Genotype 1 Chronic Hepatitis C Infection 9/27/2013
European Commission (EC) Approves Gilead Sciences, Inc. (GILD)' Tybost™, a New Boosting Agent for HIV Therapy 9/26/2013
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in Turkey 9/25/2013
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in Turkey 9/25/2013
Abstral® , Manufactured and Packaged by Recipharm AB for Kyowa Hakko Kirin, Has Been Approved in Japan 9/23/2013
Sosei Group Corporation's First in Class Once-Daily Dual Bronchodilator Ultibro® Breezhaler® (QVA149) Approved for the Treatment of COPD in Europe 9/23/2013
Orexo AB Announces the Approval of Abstral® in Japan 9/20/2013
Vectura Group plc (VEC.L) Release: Approval of Once-Daily Dual Bronchodilator Ultibro® Inhalation Capsules in Japan (QVA149) for the Treatment of COPD 9/20/2013
Sosei Group Corporation: First in Class Once-Daily Dual Bronchodilator Ultibro Inhalation Capsules (QVA149) Approved for the Treatment of COPD in Japan 9/20/2013
GlaxoSmithKline (GSK), Theravance, Inc. (THRX)'s RELVAR™ ELLIPTA™Gains Approval in Japan for the Treatment of Asthma 9/20/2013
Skyepharma PLC (SKYEF) Release: Flutiform® Approved in Japan 9/20/2013
Four-Strain AstraZeneca PLC (AZN) Flu Vaccine Wins EU Green Light 9/20/2013
Huahai Pharma China-Approved to Produce AIDS Treatment 9/18/2013
European Commission (EC) Approves Genzyme Corporation (GENZ)'s Multiple Sclerosis Treatment Lemtrada™ (alemtuzumab) 9/17/2013
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Approval of Azacitidine for Injection 9/17/2013
FDA Approves Teva Pharmaceutical Industries Limited (TEVA)'s Generic Version of Roche (RHHBY)'s Xeloda 9/17/2013
Alexion Pharmaceuticals Inc. (ALXN)'s Soliris® (eculizumab) Receives Marketing Approval in Japan for All Patients With aHUS 9/13/2013
Medigus (MDGS.TA) Announces Marketing Approval From the Israeli Ministry of Health (MEA) for SRS™ System for the Treatment of Gastroesophageal Reflux Disease (GERD) 9/12/2013
Bayer AG (BAYN.DE)'s Stivarga® (regorafenib) Tablets Approved in Europe 8/30/2013
European Commission (EC) Approves Genzyme Corporation (GENZ)’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide) 8/30/2013
Zhejiang Beta's Conmana, a Cancer Drug, is a Big Winner 8/26/2013
Bayer AG (BAYN.DE)'s Stivarga Approved for Further Indication in Japan 8/21/2013
Alcon Canada Receives Approval for JETREA™ (Ocriplasmin) Solution for Intravitreal Injection, the First and Only Eye Medicine to Treat Sight-Threatening, Symptomatic Vitreomacular Adhesion 8/16/2013
Additional GlaxoSmithKline (GSK) Quadrivalent Intramuscular Influenza Vaccine Approved by FDA 8/16/2013
FDA Approves GlaxoSmithKline (GSK)'s HIV Drug 8/14/2013
Cosmederm Gains CFDA Approval for Topical Skin Treatment 8/12/2013
Celgene International Sárl (CELG)'s Oral Anti-Cancer Therapy Pomalidomide Gets European Commission (EC) Approval 8/9/2013
European Commission (EC) Approves Janssen-Cilag International NV (JNJ)'s VELCADE® as a Frontline Induction Therapy Before Stem Cell Transplantation 8/8/2013
Zoetis (ZTS) Joint Venture in China Receives Approval for Rui Lan An™ Swine Vaccine Against PRRS 8/5/2013
FDA Expands Age Indication for Novartis AG (NVS)'s Menveo®, First and Only Quadrivalent Meningococcal Vaccine for Infants as Young as 2 Months of Age[1] 8/2/2013
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s DPP-4 Treatment for Type 2 Diabetes Approved in China 8/1/2013
RaySearch Laboratories Receives Chinese Regulatory Approval for RayStation® 7/26/2013
Warner Chilcott, PLC (WCRX) Announces FDA Approval of New Oral Contraceptive 7/25/2013
GlaxoSmithKline (GSK) Release: Tafinlar™ and Mekinist™ Approved in Canada for Metastatic Melanoma 7/24/2013
Novaliq GmbH Announces European Market Approval for NovaTears™ OTC 7/23/2013
Pfizer Inc. (PFE)'s Arthritis Drug Xeljanz Approved in Switzerland, Argentina, Kuwait, United Arab Emirates 7/15/2013
Roche (RHHBY) Wins Conditional EU Approval for Cancer Drug Erivedge 7/15/2013
TGA of Australia Approves Vertex Pharmaceuticals (MA) (VRTX)'s KALYDECO for Cystic Fbrosis 7/10/2013
FDA Approves Orexo AB's New Drug to Fight Opioid Addiction 7/9/2013
Cell Therapeutics, Inc. (CTIC) Release: Market Access Granted in Italy for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI™ (pixantrone) 7/8/2013
FDA OKs Hisamitsu Pharmaceutical's First Nonhormonal Drug for Hot Flashes 7/2/2013
Sanofi (France) (SAN.PA)'s Diabetes Treatment Lyxumia Approved in Japan 6/28/2013
FDA Approves Teva Pharmaceutical Industries Limited (TEVA) Drug as First OTC Morning After Pill, Lifts Age Limit 6/21/2013
Roche (RHHBY)'s Avastin Approved in Japan for Treatment of Aggressive Brain Cancer 6/18/2013
Apricus Biosciences (APRI) Receives European Approval for Vitaros® for the Treatment of Erectile Dysfunction 6/10/2013
FDA Approves Sanofi Pasteur (SASY.PA) Influenza Vaccine 6/10/2013
FDA OKs Flamel Technologies (FLML)' Bloxiverz 6/3/2013
FDA Approves Two GlaxoSmithKline (GSK) Melanoma Drugs 5/31/2013
European Commission (EC) Approves Gilead Sciences, Inc. (GILD)'s Stribild as Single Tablet Regimen for HIV-1 Treatment 5/28/2013
GlaxoSmithKline (GSK)'s BREO™ ELLIPTA™ Receives Regulatory Approval in U.S. 5/13/2013
FDA OKs Novartis AG (NVS) Drug for a Form of Childhood Arthritis 5/13/2013
FDA Approves GlaxoSmithKline (GSK)/Theravance, Inc. (THRX) Drug for COPD Lung Disease 5/13/2013
Optimer Pharmaceuticals, Inc. (OPTR)'s DIFICID® Tablets Approved in Australia 4/26/2013
European Commission (EC) Gives Green Light to New 6-in-1 Childhood Vaccine From Sanofi Pasteur (SASY.PA) 4/23/2013
Warner Chilcott, PLC (WCRX) Announces FDA Approval of New Oral Contraceptive 4/23/2013
BioAlliance Pharma's Sitavig® Receives Market Authorization in the U.S. for the Treatment of Herpes Labialis 4/16/2013
Sun Pharmaceutical Industries Ltd Gets FDA Nod for Generic Version of Januvia 4/16/2013
Warner Chilcott, PLC (WCRX) Receives FDA Approval of DORYX Delayed-Release 200 Mg Tablets 4/12/2013
FDA Approves Duchesnay's Diclegis for Morning Sickness 4/9/2013
Genzyme Corporation (GENZ)'s AUBAGIO® Approved in Argentina for MS 4/8/2013
Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Approval for Oral Contraceptive 4/2/2013
Astellas Pharma Inc. (YPH.BE)'s Acofide Approved in Japan 3/29/2013
Bayer AG (BAY.F)'s Colorectal Cancer Drug Stivarga Bags Approval in Japan 3/26/2013
Novartis AG (NVS)' TOBI Podhaler Gets FDA Approval 3/25/2013
Genmab A/S (GEN.CO) and GlaxoSmithKline (GSK)'s Arzerra Receives Approval in Japan 3/25/2013
Pfizer Inc. (PFE)'s XELJANZ Receives Approval in Japan 3/25/2013
Pfizer Inc. (PFE), Protalix Biotherapeutics, Inc. (PLX) Type I Gaucher Disease Drug Uplyso Gets Brazilian Approval 3/19/2013
Novartis AG (NVS) Says Alcon, Inc. (ACL)'s Eye Drug Jetrea Gets EU Approval 3/18/2013
EU Approves Roche (RHHBY)'s Perjeta to Treat Metastatic Breast Cancer 3/6/2013
Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S (LUN.CO) Wins Approval for Monthly Abilify Shot 3/1/2013
Novartis AG (NVS)'s Ilaris Cleared for Gouty Arthritis in EU 3/1/2013
Novozymes Biopharma's rAlbumin Approved in Japan as MAQUET Expands Into New Market 2/28/2013
Lundbeck Inc. (LUN.CO) Given EU Nod for Alcohol Dependence Drug 2/28/2013
FDA Approves Shionogi, Inc.'s Drug for Painful Intercourse in Women 2/27/2013
Pfizer Inc. (PFE) Gains China Approval of Drug for Kinase-Specific Lung Cancer 2/26/2013
FDA Approves Genentech (RHHBY)'s Drug for Late-Stage Metastatic Breast Cancer 2/26/2013
Lupin Ltd. (LUPN.BO) Receives FDA Nod for Suprax Oral Suspension 2/22/2013
Teva Pharmaceutical Industries Limited (TEVA) Announces FDA Approval of Generic Adderall XR® 2/15/2013
Torrent Pharmaceuticals Ltd. Gains on FDA Nod for Generics of Actos 2/15/2013
Aurobindo Pharma Gets FDA Nod for Anti-Diabetes Drug 2/15/2013
Celgene Corporation (CELG) Gains SFDA Approval for Multiple Myeloma Treatment 2/13/2013
Sun Pharmaceutical Industries Ltd Receives U.S. Nod for Cancer Drug "Doxil" 2/7/2013
FDA OKs Warner Chilcott, PLC (WCRX)'s Ulcerative Colitis Product 2/6/2013
Sanofi (France) (SAN.PA) Says Zaltrap Approved in Europe for Bowel Cancer 2/5/2013
Sanofi (France) (SAN.PA)'s Diabetes Drug Lyxumia Approved in Europe 2/4/2013
FDA Approves 3 New Diabetes Drugs From Takeda Pharmaceutical Co. Ltd. (TKPYY) 1/29/2013
Meda AB (MEDA-A.ST)'s Dymista Approved in Europe 1/24/2013
FDA Approves Novartis AG (NVS)'s Exjade in Patients With Genetic Blood Disorder 1/24/2013
Lupin Ltd. (LUPN.BO) Gets U.S. Nod for 7th Oral Contraceptive 1/23/2013
Novartis AG (NVS) Wins EU Backing for First Meningitis B Vaccine 1/22/2013
Novo Nordisk A/S (NVO) Gets Green Light for Tresiba in EU 1/22/2013
ThromboGenics NV (TBGNF), Novartis AG (NVS) Win EU OK for Jetrea Eye Drug 1/21/2013
EU Approves Johnson & Johnson (JNJ)'s Single Pill Prezista for HIV 1/16/2013
Janssen-Cilag AG Release: ZYTIGA® Approved in the EU for Use in the Treatment of Metastatic Castration-Resistant Prostate Cancer Before Chemotherapy 1/11/2013
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Eliquis Approved in Japan 12/27/2012
UCB, Inc. (UCBJF.PK) Gets Japan Clearance for Two New Drugs 12/27/2012
Novo Nordisk A/S (NVO) Gains as Japan Approves Ryzodeg 12/27/2012
FDA Approves Roche (RHHBY)'s Tamiflu for Infants 12/27/2012